English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Planned Parenthood
Trending
+
Pharmaceuticals
Patient Daily
| Mar 25, 2026
Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+
Pharmaceuticals
Patient Daily
| Mar 25, 2026
Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial
+
Pharmaceuticals
Patient Daily
| Mar 25, 2026
Lilly reports late-stage diabetes data for triple-G agonist retatrutide
+
Pharmaceuticals
Patient Daily
| Mar 25, 2026
AstraZeneca announces Shanghai cell therapy manufacturing base to support China strategy
No Results
